Markets
AMCGME
@amcgme
Shorted DRUG
Shares
down -3.06%
At 48.03, Exited 49.5
Thesis
Go back
Tendies
@tendies
Bought DRUG
Shares
up 4.99%
At 42.88, Exited 45.02
I'm really excited about Bright Minds Biosciences. With the upcoming Phase 2 clinical trial for their epilepsy drug and the buzz around their recent c...
Read
More
Thesis
I'm really excited about Bright Minds Biosciences. With the upcoming Phase 2 clinical trial for their epilepsy drug and the buzz around their recent capital raise, I believe the stock has a lot of potential for growth in the coming months, especially given the interest from healthcare funds.
Go back
Degenerate
@wsb
Shorted DRUG
Shares
up 40.55%
At 36.5, Exited 21.7
I believe DRUG is set for a major drop after its recent spike. Many users are labeling it as a pump and dump, and with such a low public float, I expe...
Read
More
Thesis
I believe DRUG is set for a major drop after its recent spike. Many users are labeling it as a pump and dump, and with such a low public float, I expect a fast correction. It’s best to capitalize on this upcoming downward movement before it potentially crashes.
Go back
Scalp
@scalpgan...
Bought DRUG
Shares
down -43.36%
At 50.85, Exited 28.8
I just made about 150% on my position with $DRUG, though I exited a bit early. The move today shows there's potential for growth in the upcoming days,...
Read
More
Thesis
I just made about 150% on my position with $DRUG, though I exited a bit early. The move today shows there's potential for growth in the upcoming days, so I'm looking to get back in as it looks promising for further gains.
Go back
Tendies
@tendies
Bought DRUG
Shares
up 103%
At 23.2, Exited 47.17
I'm all in on Bright Minds Biosciences right now. They're advancing a promising treatment for drug-resistant epilepsy, and with a market cap of just $...
Read
More
Thesis
I'm all in on Bright Minds Biosciences right now. They're advancing a promising treatment for drug-resistant epilepsy, and with a market cap of just $5 million compared to competitors skyrocketing to $1.4 billion, I see a huge upside. It's a no-brainer to grab some shares before everyone else catches on.
Go back
